Newcastle Upon Tyne, United Kingdom · Founded 2016 · Privately Held (backing)
Developer of a biological age test designed to discover, measure, and optimize longevity. GlycanAge is based in Newcastle Upon Tyne, United Kingdom and was founded in 2016. Its last reported valuation was $17 million in Jan 2024. It has raised $15.5 million.
Last reported valuation
$17.0M
Oct 2026
Priced at
—
Total raised
$15.5M
Last round
—
Cap table — not yet on record
GlycanAge's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GlycanAge with a free account
·The complete investor list: 24 names
·Watch GlycanAge: the Monday email on marks, rounds and moves
